AI is changing the way pharma delivers omnichannel, but is it improving engagement or just adding to the noise? In this episode, we explore how pharma can avoid repeating past mistakes, how hyper-personalization and localization are being applied across markets, and why human insight is the key to making AI truly effective in reaching doctors.
All content for DELTAMV’S INSIGHT BITES is the property of DeltaMV Knowledge Solutions and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
AI is changing the way pharma delivers omnichannel, but is it improving engagement or just adding to the noise? In this episode, we explore how pharma can avoid repeating past mistakes, how hyper-personalization and localization are being applied across markets, and why human insight is the key to making AI truly effective in reaching doctors.
Doctors’ prescribing behavior varies across healthcare settings and influenced by factors such as patient profiles, the work environment, and doctor’s pain points in each setting. Although originator drugs are prescribed at a higher rate in private medical centers compared to public ones, their use is still constrained, especially in context of doctor-owned clinics. In this episode, we discuss the underlying factors influencing this dynamic and the stories behind it. Hành vi kê đơn của bác sĩ...
DELTAMV’S INSIGHT BITES
AI is changing the way pharma delivers omnichannel, but is it improving engagement or just adding to the noise? In this episode, we explore how pharma can avoid repeating past mistakes, how hyper-personalization and localization are being applied across markets, and why human insight is the key to making AI truly effective in reaching doctors.
